• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者的临床症状学与药物依从性

Clinical symptomatology and drug compliance in schizophrenic patients.

作者信息

Bartkó G, Herczeg I, Zádor G

机构信息

National Institute for Nervous and Mental diseases, Budapest, Hungary.

出版信息

Acta Psychiatr Scand. 1988 Jan;77(1):74-6. doi: 10.1111/j.1600-0447.1988.tb05080.x.

DOI:10.1111/j.1600-0447.1988.tb05080.x
PMID:2894746
Abstract

The differences in the psychopathologic status of 26 complaint and 32 noncomplaint schizophrenic patients were evaluated on the basis of rating scales used at discharge. Noncomplaint patients had significantly higher scores for grandiosity, lack of feeling of illness and insight into it. Their score for global psychopathological state and disturbance in social adjustment was also significantly higher. The compliant patients had significantly higher score for self-rated depression.

摘要

根据出院时使用的评定量表,对26例有主诉的精神分裂症患者和32例无主诉的精神分裂症患者的心理病理状态差异进行了评估。无主诉患者在夸大、无病感及自知力方面得分显著更高。他们在整体心理病理状态和社会适应障碍方面的得分也显著更高。有主诉的患者在自评抑郁方面得分显著更高。

相似文献

1
Clinical symptomatology and drug compliance in schizophrenic patients.精神分裂症患者的临床症状学与药物依从性
Acta Psychiatr Scand. 1988 Jan;77(1):74-6. doi: 10.1111/j.1600-0447.1988.tb05080.x.
2
[Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].[氟司必林与氟奋乃静治疗精神分裂症患者的比较研究]
MMW Munch Med Wochenschr. 1980 Dec 5;122(49):1758-60.
3
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Acta Psychiatr Scand. 1983 May;67(5):339-52. doi: 10.1111/j.1600-0447.1983.tb00351.x.
4
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Am J Psychiatry. 1982 Mar;139(3):312-8. doi: 10.1176/ajp.139.3.312.
5
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.抑郁及锥体外系症状与临床疗效:氟奋乃静与三氟噻吨对精神分裂症门诊患者维持治疗的比较试验
Br J Psychiatry. 1979 Dec;135:515-23. doi: 10.1192/bjp.135.6.515.
6
Lowest effective dose of depot neuroleptics.长效抗精神病药物的最低有效剂量。
Br J Psychiatry. 1992 Mar;160:422-3. doi: 10.1192/bjp.160.3.422.
7
A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.氟斯必灵与癸酸氟奋乃静治疗精神分裂症的双盲对照研究。
Can J Psychiatry. 1982 Nov;27(7):593-6. doi: 10.1177/070674378202700714.
8
Low dose medication strategies in the maintenance treatment of schizophrenia.
Schizophr Bull. 1983;9(4):528-32. doi: 10.1093/schbul/9.4.528.
9
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.精神分裂症门诊患者的治疗依从性:患者态度、人口统计学、临床及治疗变量
Psychiatr Danub. 2008 Mar;20(1):42-52.
10
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.癸酸氟哌噻吨与癸酸氟奋乃静治疗慢性精神分裂症的双盲比较
Acta Psychiatr Scand. 1979 Oct;60(4):313-22. doi: 10.1111/j.1600-0447.1979.tb00281.x.

引用本文的文献

1
Physicochemical Properties, Drug Release and In Situ Depot-Forming Behaviors of Alginate Hydrogel Containing Poorly Water-Soluble Aripiprazole.含难溶性阿立哌唑的海藻酸盐水凝胶的物理化学性质、药物释放及原位成 depot 行为
Gels. 2024 Nov 29;10(12):781. doi: 10.3390/gels10120781.
2
Do the Components of Attenuated Positive Symptoms Truly Represent One Construct?减缩的阳性症状的组成部分真的代表一个结构吗?
Schizophr Bull. 2023 May 3;49(3):788-798. doi: 10.1093/schbul/sbac182.
3
Multidimensional Evaluation of Awareness in Prader-Willi Syndrome.
普拉德-威利综合征意识的多维评估
J Clin Med. 2021 May 7;10(9):2007. doi: 10.3390/jcm10092007.
4
Perceptions of ADHD Among Diagnosed Children and Their Parents: A Systematic Review Using the Common-Sense Model of Illness Representations.诊断为 ADHD 的儿童及其父母对 ADHD 的认知:基于疾病共同感知模型的系统评价。
Clin Child Fam Psychol Rev. 2018 Mar;21(1):57-93. doi: 10.1007/s10567-017-0245-2.
5
Recent Neurobiological Insights into the Concept of Insight in Psychosis.近期关于精神病中顿悟概念的神经生物学见解
Indian J Psychol Med. 2016 May-Jun;38(3):189-93. doi: 10.4103/0253-7176.183077.
6
Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms.治疗抵抗还是对治疗有抵抗?精神病症状控制不佳患者的抗精神病药物血浆水平
J Psychopharmacol. 2015 Aug;29(8):892-7. doi: 10.1177/0269881115576688. Epub 2015 Mar 18.
7
Insight in schizophrenia: relationship to positive, negative and neurocognitive dimensions.精神分裂症的洞察:与阳性、阴性及神经认知维度的关系
Indian J Psychol Med. 2015 Jan-Mar;37(1):5-11. doi: 10.4103/0253-7176.150797.
8
Trifluoperazine versus placebo for schizophrenia.三氟拉嗪与安慰剂治疗精神分裂症的对比
Cochrane Database Syst Rev. 2014 Jan 11;2014(1):CD010226. doi: 10.1002/14651858.CD010226.pub2.
9
Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.埃塞俄比亚精神分裂症患者药物治疗不依从的原因之观点:一项对患者、照护者和卫生工作者的定性研究。
BMC Psychiatry. 2013 Jun 17;13:168. doi: 10.1186/1471-244X-13-168.
10
Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.埃塞俄比亚人群中治疗精神病药物的依从性:发生率及危险因素
BMC Clin Pharmacol. 2012 Jun 18;12:10. doi: 10.1186/1472-6904-12-10.